S-adenosylmethionine (SAMe) therapy in liver disease: A review of current evidence and clinical utility

Journal of Hepatology

Volumn 57, Issue 5, 2012, Pages 1097-1109

  Anstee, Quentin M ^a   Day, Christopher P ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Hepatitis; Oxidative stress; S adenosyl l methionine; SAMe; Steatohepatitis

Indexed keywords

ALPHA INTERFERON; ALPHA TOCOPHEROL; BETAINE; BIOGENIC AMINE; CYANOCOBALAMIN; FOLIC ACID; GLUTATHIONE; HISTONE; NUCLEIC ACID; PHOSPHOLIPID; PYRIDOXINE; REACTIVE OXYGEN METABOLITE; RIBAVIRIN; S ADENOSYLMETHIONINE; TAUROURSODEOXYCHOLIC ACID; URSODEOXYCHOLIC ACID;

ALCOHOL LIVER CIRRHOSIS; ALCOHOL LIVER DISEASE; APOPTOSIS; CELL DAMAGE; CHOLESTASIS; CHRONIC LIVER DISEASE; CLINICAL PRACTICE; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG TOLERABILITY; HEPATITIS C; HUMAN; INTRAHEPATIC CHOLESTASIS; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER INJURY; LIVER PROTECTION; METHYLATION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT DURATION; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

CHRONIC DISEASE; EVIDENCE-BASED MEDICINE; HUMANS; LIVER DISEASES; S-ADENOSYLMETHIONINE; SEVERITY OF ILLNESS INDEX;

EID: 84867573089     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2012.04.041     Document Type: Review

References (126)

1. H. Malhi, and G.J. Gores Cellular and molecular mechanisms of liver injury Gastroenterology 134 6 2008 1641 1654
2. Q.M. Anstee, M. Wright, R. Goldin, and M.R. Thursz Parenchymal extinction: coagulation and hepatic fibrogenesis Clin Liver Dis 13 1 2009 117 126
3. H. Malhi, G.J. Gores, and J.J. Lemasters Apoptosis and necrosis in the liver: a tale of two deaths? Hepatology 43 2 Suppl. 1 2006 S31 44
4. R.C. Benyon, and J.P. Iredale Is liver fibrosis reversible? Gut 46 4 2000 443 446
5. J.P. Iredale, R.C. Benyon, J. Pickering, M. McCullen, M. Northrop, and S. Pawley Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors J Clin Invest 102 3 1998 538 549
6. Q.M. Anstee, A.K. Daly, and C.P. Day Genetics of alcoholic and nonalcoholic fatty liver disease Semin Liver Dis 31 2 2011 128 146
7. M. Plauth, E. Cabre, O. Riggio, M. Assis-Camilo, M. Pirlich, and J. Kondrup ESPEN guidelines on enteral nutrition: liver disease Clin Nutr 25 2 2006 285 294
8. C.S. Lieber S-adenosyl-l-methionine: its role in the treatment of liver disorders Am J Clin Nutr 76 5 2002 1183S 1187S
9. M.L. Martinez-Chantar, E.R. Garcia-Trevijano, M.U. Latasa, I. Perez-Mato, M.M. Sanchez del Pino, and F.J. Corrales Importance of a deficiency in S-adenosyl-l-methionine synthesis in the pathogenesis of liver injury Am J Clin Nutr 76 5 2002 1177S 1182S
10. J.M. Mato, and S.C. Lu Role of S-adenosyl-l-methionine in liver health and injury Hepatology 45 5 2007 1306 1312
11. V. Purohit, M.F. Abdelmalek, S. Barve, N.J. Benevenga, C.H. Halsted, and N. Kaplowitz Role of S-adenosylmethionine, folate, and betaine in the treatment of alcoholic liver disease: summary of a symposium Am J Clin Nutr 86 1 2007 14 24
12. J.M. Mato, F.J. Corrales, S.C. Lu, and M.A. Avila S-adenosylmethionine: a control switch that regulates liver function FASEB J 16 1 2002 15 26
13. G.L. Catoni S-adenosylmethionine; a new intermediate formed enzymatically from l-methionine and adenosinetriphosphate J Biol Chem 204 1 1953 403 416
14. S.H. Mudd Activation of methionine for transmethylation. V. The mechanism of action of the methionine-activating enzyme J Biol Chem 237 1962 1372 1375
15. M. Kotb, S.H. Mudd, J.M. Mato, A.M. Geller, N.M. Kredich, and J.Y. Chou Consensus nomenclature for the mammalian methionine adenosyltransferase genes and gene products Trends Genet: TIG 13 2 1997 51 52
16. M. Kotb, and A.M. Geller Methionine adenosyltransferase: structure and function Pharmacol Ther 59 2 1993 125 143
17. B. Gil, M. Casado, M.A. Pajares, L. Bosca, J.M. Mato, and P. Martin-Sanz Differential expression pattern of S-adenosylmethionine synthetase isoenzymes during rat liver development Hepatology 24 4 1996 876 881
18. L. Torres, M.A. Avila, M.V. Carretero, M.U. Latasa, J. Caballeria, and G. Lopez-Rodas Liver-specific methionine adenosyltransferase MAT1A gene expression is associated with a specific pattern of promoter methylation and histone acetylation: implications for MAT1A silencing during transformation FASEB J 14 1 2000 95 102
19. M.A. Avila, J. Mingorance, M.L. Martinez-Chantar, M. Casado, P. Martin-Sanz, and L. Bosca Regulation of rat liver S-adenosylmethionine synthetase during septic shock: role of nitric oxide Hepatology 25 2 1997 391 396
20. E. Sanchez-Gongora, F. Ruiz, J. Mingorance, W. An, F.J. Corrales, and J.M. Mato Interaction of liver methionine adenosyltransferase with hydroxyl radical FASEB J 11 12 1997 1013 1019
21. F. Ruiz, F.J. Corrales, C. Miqueo, and J.M. Mato Nitric oxide inactivates rat hepatic methionine adenosyltransferase in vivo by S-nitrosylation Hepatology 28 4 1998 1051 1057
22. S.C. Lu S-adenosylmethionine Int J Biochem Cell Biol 32 4 2000 391 395
23. C.S. Lieber, and L. Packer S-adenosylmethionine: molecular, biological, and clinical aspects - an introduction Am J Clin Nutr 76 5 2002 1148S 1150S
24. X. Ou, H. Yang, K. Ramani, A.I. Ara, H. Chen, and J.M. Mato Inhibition of human betaine-homocysteine methyltransferase expression by S-adenosylmethionine and methylthioadenosine Biochem J 401 1 2007 87 96
25. L.W. Kinsell, H.A. Harper, H.C. Barton, M.E. Hutchin, and J.R. Hess Studies in methionine and sulfur metabolism. I. The fate of intravenously administered methionine, in normal individuals and in patients with liver damage J Clin Investig 27 5 1948 677 688
26. A.M. Duce, P. Ortiz, C. Cabrero, and J.M. Mato S-adenosyl-l-methionine synthetase and phospholipid methyltransferase are inhibited in human cirrhosis Hepatology 8 1 1988 65 68
27. M.A. Avila, C. Berasain, L. Torres, A. Martin-Duce, F.J. Corrales, and H. Yang Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma J Hepatol 33 6 2000 907 914
28. S.C. Lu, L. Alvarez, Z.Z. Huang, L. Chen, W. An, and F.J. Corrales Methionine adenosyltransferase 1A knockout mice are predisposed to liver injury and exhibit increased expression of genes involved in proliferation Proc Natl Acad Sci USA 98 10 2001 5560 5565
29. Q.M. Anstee, and R.D. Goldin Mouse models in non-alcoholic fatty liver disease and steatohepatitis research Int J Exp Pathol 87 1 2006 1 16
30. J. Cai, Z. Mao, J.J. Hwang, and S.C. Lu Differential expression of methionine adenosyltransferase genes influences the rate of growth of human hepatocellular carcinoma cells Cancer Res. 58 7 1998 1444 1450
31. M.U. Latasa, A. Boukaba, E.R. Garcia-Trevijano, L. Torres, J.L. Rodriguez, and J. Caballeria Hepatocyte growth factor induces MAT2A expression and histone acetylation in rat hepatocytes: role in liver regeneration FASEB J 15 7 2001 1248 1250
32. E.R. Garcia-Trevijano, M.U. Latasa, M.V. Carretero, C. Berasain, J.M. Mato, and M.A. Avila S-adenosylmethionine regulates MAT1A and MAT2A gene expression in cultured rat hepatocytes: a new role for S-adenosylmethionine in the maintenance of the differentiated status of the liver FASEB J 14 15 2000 2511 2518
33. Z.Z. Huang, Z. Mao, J. Cai, and S.C. Lu Changes in methionine adenosyltransferase during liver regeneration in the rat Am J Physiol 275 1 Pt 1 1998 G14 21
34. M.L. Martinez-Chantar, F.J. Corrales, L.A. Martinez-Cruz, E.R. Garcia-Trevijano, Z.Z. Huang, and L. Chen Spontaneous oxidative stress and liver tumors in mice lacking methionine adenosyltransferase 1A FASEB J 16 10 2002 1292 1294
35. L. Chen, Y. Zeng, H. Yang, T.D. Lee, S.W. French, and F.J. Corrales Impaired liver regeneration in mice lacking methionine adenosyltransferase 1A FASEB J 18 7 2004 914 916
36. R.M. Pascale, V. Marras, M.M. Simile, L. Daino, G. Pinna, and S. Bennati Chemoprevention of rat liver carcinogenesis by S-adenosyl-l-methionine: a long-term study Cancer Res 52 18 1992 4979 4986
37. R.M. Pascale, M.M. Simile, M.R. De Miglio, A. Nufris, L. Daino, and M.A. Seddaiu Chemoprevention by S-adenosyl-l-methionine of rat liver carcinogenesis initiated by 1,2-dimethylhydrazine and promoted by orotic acid Carcinogenesis 16 2 1995 427 430
38. J.D. Finkelstein, and J.J. Martin Methionine metabolism in mammals. Adaptation to methionine excess J Biol Chem 261 4 1986 1582 1587
39. D.F. Hardwick, D.A. Applegarth, D.M. Cockcroft, P.M. Ross, and R.J. Cder Pathogenesis of methionine-induced toxicity Metabolism 19 5 1970 381 391
40. H. Jaeschke Reactive oxygen and mechanisms of inflammatory liver injury: present concepts J Gastroenterol Hepatol 26 Suppl. 1 2011 173 179
41. B.L. Copple, H. Jaeschke, and C.D. Klaassen Oxidative stress and the pathogenesis of cholestasis Semin Liver Dis 30 2 2010 195 204
42. Z. Song, Z. Zhou, T. Chen, D. Hill, J. Kang, and S. Barve S-adenosylmethionine (SAMe) protects against acute alcohol induced hepatotoxicity in mice J Nutr Biochem 14 10 2003 591 597
43. C. Garcia-Ruiz, A. Morales, A. Colell, A. Ballesta, J. Rodes, and N. Kaplowitz Feeding S-adenosyl-l-methionine attenuates both ethanol-induced depletion of mitochondrial glutathione and mitochondrial dysfunction in periportal and perivenous rat hepatocytes Hepatology 21 1 1995 207 214
44. A. Colell, C. Garcia-Ruiz, M. Miranda, E. Ardite, M. Mari, and A. Morales Selective glutathione depletion of mitochondria by ethanol sensitizes hepatocytes to tumor necrosis factor Gastroenterology 115 6 1998 1541 1551
45. A. Colell, C. García-Ruiz, A. Morales, A. Ballesta, M. Ookhtens, and J. Rodés Transport of reduced glutathione in hepatic mitochondria and mitoplasts from ethanol-treated rats: effect of membrane physical properties and S-adenosyl-l-methionine Hepatology 26 3 1997 699 708
46. G. Vendemiale, E. Altomare, T. Trizio, C. Le Grazie, C. Di Padova, and M.T. Salerno Effects of oral S-adenosyl-l-methionine on hepatic glutathione in patients with liver disease Scand J Gastroenterol 24 4 1989 407 415
47. D. Santini, B. Vincenzi, C. Massacesi, A. Picardi, U.V. Gentilucci, and V. Esposito S-adenosylmethionine (AdoMet) supplementation for treatment of chemotherapy-induced liver injury Anticancer Res 23 6D 2003 5173 5179
48. B. Vincenzi, S. Daniele, A.M. Frezza, P. Berti, U. Vespasiani, and A. Picardi The role of S-adenosylmethionine in preventing oxaliplatin-induced liver toxicity: a retrospective analysis in metastatic colorectal cancer patients treated with bevacizumab plus oxaliplatin-based regimen Support Care Cancer 20 1 2012 135 139
49. B. Vincenzi, D. Santini, A.M. Frezza, P. Berti, U. Vespasiani, and A. Picardi The role of S-adenosyl methionine in preventing FOLFOX-induced liver toxicity: a retrospective analysis in patients affected by resected colorectal cancer treated with adjuvant FOLFOX regimen Expert Opin Drug Saf 10 3 2011 345 349
50. N. Veal, C.L. Hsieh, S. Xiong, J.M. Mato, S. Lu, and H. Tsukamoto Inhibition of lipopolysaccharide-stimulated TNF-alpha promoter activity by S-adenosylmethionine and 5'-methylthioadenosine Am J Physiol Gastrointest Liver Physiol 287 2 2004 G352 362
51. R.K. Chawla, W.H. Watson, C.E. Eastin, E.Y. Lee, J. Schmidt, and C.J. McClain S-adenosylmethionine deficiency and TNF-alpha in lipopolysaccharide- induced hepatic injury Am J Physiol 275 1 Pt 1 1998 G125 129
52. Z. Song, S. Uriarte, R. Sahoo, T. Chen, S. Barve, and D. Hill S-adenosylmethionine (SAMe) modulates interleukin-10 and interleukin-6, but not TNF, production via the adenosine (A2) receptor Biochim Biophys Acta 1743 3 2005 205 213
53. H. Hevia, M. Varela-Rey, F.J. Corrales, C. Berasain, M.L. Martinez-Chantar, and M.U. Latasa 5′-Methylthioadenosine modulates the inflammatory response to endotoxin in mice and in rat hepatocytes Hepatology 39 4 2004 1088 1098
54. Z. Song, S. Barve, T. Chen, W. Nelson, S. Uriarte, and D. Hill S-adenosylmethionine (AdoMet) modulates endotoxin stimulated interleukin-10 production in monocytes Am J Physiol Gastrointest Liver Physiol 284 6 2003 G949 955
55. C. Benz, S. Angermuller, P. Kloters-Plachky, P. Sauer, W. Stremmel, and A. Stiehl Effect of S-adenosylmethionine versus tauroursodeoxycholic acid on bile acid-induced apoptosis and cytolysis in rat hepatocytes Eur J Clin Invest 28 7 1998 577 583
56. C.R. Webster, P. Boria, P. Usechak, and M.S. Anwer S-adenosylmethionine and cAMP confer differential cytoprotection against bile acid-induced apoptosis in canine renal tubular cells and primary rat hepatocytes Vet Ther 3 4 2002 474 484
57. H. Ishii, M. Adachi, J.C. Fernandez-Checa, A.I. Cederbaum, I.V. Deaciuc, and A.A. Nanji Role of apoptosis in alcoholic liver injury Alcohol Clin Exp Res 27 7 2003 1207 1212
58. E. Ansorena, E.R. Garcia-Trevijano, M.L. Martinez-Chantar, Z.Z. Huang, L. Chen, and J.M. Mato S-adenosylmethionine and methylthioadenosine are antiapoptotic in cultured rat hepatocytes but proapoptotic in human hepatoma cells Hepatology 35 2 2002 274 280
59. E.V. Golovanova, A.V. Petrakov, and K.K. Noskova Intrahepatic cholestasis in chronic liver diseases Eksp Klin Gastroenterol 2 2011 58 67
60. F. Hirata, and J. Axelrod Phospholipid methylation and biological signal transmission Science 209 4461 1980 1082 1090
61. F. Hirata, S. Toyoshima, J. Axelrod, and M.J. Waxdal Phospholipid methylation: a biochemical signal modulating lymphocyte mitogenesis Proc Natl Acad Sci USA 77 2 1980 862 865
62. F. Hirata, O.H. Viveros, E.J. Diliberto Jr., and J. Axelrod Identification and properties of two methyltransferases in conversion of phosphatidylethanolamine to phosphatidylcholine Proc Natl Acad Sci USA 75 4 1978 1718 1721
63. J.S. Dooley, A.S. Lok, A.K. Burroughs, and E.J. Heathcote Sherlock's diseases or the liver & biliary system 12th ed. 2011 Wiley-Blackwell
64. J.A. Gonzalez-Correa, J.P. De La Cruz, E. Martin-Aurioles, M.A. Lopez-Egea, P. Ortiz, and F. Sanchez de la Cuesta Effects of S-adenosyl-l-methionine on hepatic and renal oxidative stress in an experimental model of acute biliary obstruction in rats Hepatology 26 1 1997 121 127
65. H. Yang, K. Ramani, M. Xia, K.S. Ko, T.W. Li, and P. Oh Dysregulation of glutathione synthesis during cholestasis in mice. molecular mechanisms and therapeutic implications Hepatology 49 6 2009 1982 1991
66. G. Fiorelli S-adenosylmethionine in the treatment of intrahepatic cholestasis of chronic liver disease: a field trial Curr Ther Res Clin Exp 60 6 1999 335 348
67. M. Frezza, C. Surrenti, G. Manzillo, F. Fiaccadori, M. Bortolini, and C. Di Padova Oral S-adenosylmethionine in the symptomatic treatment of intrahepatic cholestasis. A double-blind, placebo-controlled study Gastroenterology 99 1 1990 211 215
68. G. Manzillo, F. Piccinino, C. Surrenti, M. Frezza, G.A. Giudici, and C. Le Grazie Multicentre double-blind placebo-controlled study of intravenous and oral s-adenosyl-l-methionine (SAMe) in cholestatic patients with liver disease Drug Invest 1992 90 100
69. B. Qin, S. Guo, Y. Zhao, S. Zou, Q. Zhang, and Z. Wang A trial of ademetionine in the treatment of intrahepatic biliary stasis viral hepatitis Zhonghua Gan Zang Bing Za Zhi 8 3 2000 158 160
70. M.L. Hardy, I. Coulter, S.C. Morton, J. Favreau, S. Venuturupalli, and F. Chiappelli S-adenosyl-l-methionine for treatment of depression, osteoarthritis, and liver disease Evid Rep Technol Assess (Summ) 64 2003 1 3
71. T. Pusl, and U. Beuers Intrahepatic cholestasis of pregnancy Orphanet J Rare Dis 2 2007 26
72. N. Roncaglia, A. Locatelli, A. Arreghini, F. Assi, I. Cameroni, and J.C. Pezzullo A randomised controlled trial of ursodeoxycholic acid and S-adenosyl-l-methionine in the treatment of gestational cholestasis BJOG 2 2004 17 21
73. R.F. Burrows, O. Clavisi, and E. Burrows Interventions for treating cholestasis in pregnancy Cochrane Database Syst Rev 4 2001 CD000493
74. B. Gao, and R. Bataller Alcoholic liver disease: pathogenesis and new therapeutic targets Gastroenterology 141 5 2011 1572 1585
75. C.H. Halsted, and V. Medici Vitamin-dependent methionine metabolism and alcoholic liver disease Adv Nutr 2 5 2011 421 427
76. L. Lumeng The role of acetaldehyde in mediating the deleterious effect of ethanol on pyridoxal 5'-phosphate metabolism J Clin Investig 62 2 1978 286 293
77. T.D. Lee, M.R. Sadda, M.H. Mendler, T. Bottiglieri, G. Kanel, and J.M. Mato Abnormal hepatic methionine and glutathione metabolism in patients with alcoholic hepatitis Alcohol Clin Exp Res 28 1 2004 173 181
78. C. Cabrero, A.M. Duce, P. Ortiz, S. Alemany, and J.M. Mato Specific loss of the high-molecular-weight form of S-adenosyl-l- methionine synthetase in human liver cirrhosis Hepatology 8 6 1988 1530 1534
79. A.J. Barak, H.C. Beckenhauer, D.J. Tuma, and S. Badakhsh Effects of prolonged ethanol feeding on methionine metabolism in rat liver Biochem Cell Biol 65 3 1987 230 233
80. C.S. Lieber, A. Casini, L.M. DeCarli, C.I. Kim, N. Lowe, and R. Sasaki S-adenosyl-l-methionine attenuates alcohol-induced liver injury in the baboon Hepatology 11 2 1990 165 172
81. C.H. Halsted, J.A. Villanueva, A.M. Devlin, O. Niemela, S. Parkkila, and T.A. Garrow Folate deficiency disturbs hepatic methionine metabolism and promotes liver injury in the ethanol-fed micropig Proc Natl Acad Sci USA 99 15 2002 10072 10077
82. C.H. Halsted, J. Villanueva, C.J. Chandler, S.P. Stabler, R.H. Allen, and L. Muskhelishvili Ethanol feeding of micropigs alters methionine metabolism and increases hepatocellular apoptosis and proliferation Hepatology 23 3 1996 497 505
83. A. Gigliozzi, R. Romeo, F. Fraioli, A. Cantafora, M. Delle Monache, and A. Cardilli Effect of S-adenosyl-l-methionine and dilinoleoylphosphatidylcholine on liver lipid composition and ethanol hepatotoxicity in isolated perfused rat liver Dig Dis Sci 43 10 1998 2211 2222
84. F. Corrales, A. Gimenez, L. Alvarez, J. Caballeria, M.A. Pajares, and H. Andreu S-adenosylmethionine treatment prevents carbon tetrachloride-induced S- adenosylmethionine synthetase inactivation and attenuates liver injury Hepatology 16 4 1992 1022 1027
85. J.M. Mato, J. Camara, J. Fernandez de Paz, L. Caballeria, S. Coll, and A. Caballero S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial J Hepatol 30 6 1999 1081 1089
86. A. Rambaldi, and C. Gluud S-adenosyl-l-methionine for alcoholic liver diseases Cochrane Database Syst Rev 2 2006 CD002235
87. V. Medici, M.C. Virata, J.M. Peerson, S.P. Stabler, S.W. French, and J.F. Gregory 3rd S-adenosyl-l-methionine treatment for alcoholic liver disease: a double-blinded, randomized, placebo-controlled trial Alcohol Clin Exp Res 35 11 2011 1960 1965
88. A.J. Sanyal American gastroenterological A. AGA technical review on nonalcoholic fatty liver disease Gastroenterology 123 5 2002 1705 1725
89. G. Marchesini, M. Brizi, A.M. Morselli-Labate, G. Bianchi, E. Bugianesi, and A.J. McCullough Association of nonalcoholic fatty liver disease with insulin resistance Am J Med 107 5 1999 450 455
90. E.E. Powell, W.G. Cooksley, R. Hanson, J. Searle, J.W. Halliday, and L.W. Powell The natural history of nonalcoholic steatohepatitis: a follow-up study of forty-two patients for up to 21 years Hepatology 11 1 1990 74 80
91. K. Nagata, H. Suzuki, and S. Sakaguchi Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis J Toxicol Sci 32 5 2007 453 468
92. K. Yamaguchi, L. Yang, S. McCall, J. Huang, X.X. Yu, and S.K. Pandey Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis Hepatology 45 6 2007 1366 1374
93. Q.M. Anstee, D. Concas, H. Kudo, A. Levene, J. Pollard, and P. Charlton Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis J Hepatol 53 3 2010 542 550
94. G.C. Farrell, C.Z. Larter, J.Y. Hou, R.H. Zhang, M.M. Yeh, and J. Williams Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression J Gastroenterol Hepatol 24 3 2009 443 452
95. J.P. Iredale Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ J Clin Invest 117 3 2007 539 548
96. M. Wortham, L. He, M. Gyamfi, B.L. Copple, and Y.J. Wan The transition from fatty liver to NASH associates with SAMe depletion in db/db mice fed a methionine choline-deficient diet Dig Dis Sci 53 10 2008 2761 2774
97. A. Cano, X. Buque, M. Martinez-Una, I. Aurrekoetxea, A. Menor, and J.L. Garcia-Rodriguez Methionine adenosyltransferase 1A gene deletion disrupts hepatic very low-density lipoprotein assembly in mice Hepatology 54 6 2011 1975 1986
98. S.C. Kalhan, J. Edmison, S. Marczewski, S. Dasarathy, L.L. Gruca, and C. Bennett Methionine and protein metabolism in non-alcoholic steatohepatitis: evidence for lower rate of transmethylation of methionine Clin Sci 121 4 2011 179 189
99. Q.M. Anstee, S. McPherson, and C.P. Day How big a problem is non-alcoholic fatty liver disease? BMJ 343 2011 d3897
100. A.J. Sanyal, N. Chalasani, K.V. Kowdley, A. McCullough, A.M. Diehl, and N.M. Bass Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis N Engl J Med 362 18 2010 1675 1685
101. J.E. Lavine, J.B. Schwimmer, M.L. Van Natta, J.P. Molleston, K.F. Murray, and P. Rosenthal Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents: the TONIC randomized controlled trial JAMA 305 16 2011 1659 1668
102. M.F. Abdelmalek, P. Angulo, R.A. Jorgensen, P.B. Sylvestre, and K.D. Lindor Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study Am J Gastroenterol 96 9 2001 2711 2717
103. M.F. Abdelmalek, S.O. Sanderson, P. Angulo, C. Soldevila-Pico, C. Liu, and J. Peter Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial Hepatology 50 6 2009 1818 1826
104. W. Bao-en Ademetionine 1,4 butanedisulphonate vs traditional Chinese medicine for the treatment of hepatocellular jaundice complicating chronic viral hepatitis Clinical Drug Invest 21 11 2001 765 773
105. Y. Tanaka, N. Nishida, M. Sugiyama, M. Kurosaki, K. Matsuura, and N. Sakamoto Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C Nat Genet 41 10 2009 1105 1109
106. V. Suppiah, M. Moldovan, G. Ahlenstiel, T. Berg, M. Weltman, and M.L. Abate IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy Nat Genet 41 10 2009 1100 1104
107. D. Ge, J. Fellay, A.J. Thompson, J.S. Simon, K.V. Shianna, and T.J. Urban Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance Nature 461 7262 2009 399 401
108. F.H. Duong, M. Filipowicz, M. Tripodi, N. La Monica, and M.H. Heim Hepatitis C virus inhibits interferon signaling through up-regulation of protein phosphatase 2A Gastroenterology 126 1 2004 263 277
109. F.H. Duong, V. Christen, M. Filipowicz, and M.H. Heim S-adenosylmethionine and betaine correct hepatitis C virus induced inhibition of interferon signaling in vitro Hepatology 43 4 2006 796 806
110. M. Filipowicz, C. Bernsmeier, L. Terracciano, F.H. Duong, and M.H. Heim S-adenosyl-methionine and betaine improve early virological response in chronic hepatitis C patients with previous nonresponse PLoS One 2010 e15492
111. J.J. Feld, A.A. Modi, R. El-Diwany, Y. Rotman, E. Thomas, and G. Ahlenstiel S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders Gastroenterology 140 3 2011 830 839
112. Q. Liu, J. Chen, L. Liu, J. Zhang, D. Wang, and L. Ma The X protein of hepatitis B virus inhibits apoptosis in hepatoma cells through enhancing the methionine adenosyltransferase 2A gene expression and reducing S-adenosylmethionine production J Biol Chem 286 19 2011 17168 17180
113. P.L. Nicastri, A. Diaferia, M. Tartagni, P. Loizzi, and M. Fanelli A randomised placebo-controlled trial of ursodeoxycholic acid and S-adenosylmethionine in the treatment of intrahepatic cholestasis of pregnancy Br J Obstet Gynaecol 105 11 1998 1205 1207
114. J. Ribalta, H. Reyes, M.C. Gonzalez, J. Iglesias, M. Arrese, and J. Poniachik S-adenosyl-l-methionine in the treatment of patients with intrahepatic cholestasis of pregnancy: a randomized, double-blind, placebo-controlled study with negative results Hepatology (Baltimore, MD) 2 1991 1084 1089
115. M. Frezza, G. Centini, G. Cammareri, C. Le Grazie, and C. Di Padova S-adenosylmethionine for the treatment of intrahepatic cholestasis of pregnancy. Results of a controlled clinical trial Hepatogastroenterology 37 Suppl. 2 1990 122 125
116. M. Frezza, G. Pozzato, L. Chiesa, G. Stramentinoli, and C. di Padova Reversal of intrahepatic cholestasis of pregnancy in women after high dose S-adenosyl-l-methionine administration Hepatology 4 2 1984 274 278
117. A. Floreani, D. Paternoster, A. Melis, and P.V. Grella S-adenosylmethionine versus ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: preliminary results of a controlled trial Eur J Obstet Gynecol Reprod Biol 67 2 1996 109 113
118. G. Lafuenti, G. Plotti, G. Nicolanti, R. Gaglione, F.G. Tibollo, and S. Mancuso Evaluation of the obstetrical risk in pregnant women with intrahepatic cholestasis treated with S-adenosyl-l-methionine Recent Prog Med 79 10 1988 420 423
119. F. Catalino, S. Scarponi, F. Cesa, G. Loiacono, and M. Bortolini Efficacy and safety of intravenous S-adenosyl-l-methionine therapy in the management of intrahepatic cholestasis of pregnancy Drug Invest 4 1992 78 82
120. E. Altomare, G. Vendemiale, G. Marchesini, C. Legrazie, and C. Dipadova Increased bioavailability of sulfurated compounds after S-adenosylmethionine (same) administration to alcoholics Biomed Soc Aspects Alcohol Alcohol 805 1988 353 356
121. R.K. Chawla, L. Gaetke, and C.J. McClain S-adenosylmethionine (Adomet) and plasma methionine clearance in alcoholic subjects Hepatology 30 4 1999 397A
122. M. Cibin, N. Gentile, M. Ferri, G. Canton, C. Legrazie, and L. Gallimberti S-adenosylmethionine (same) is effective in reducing ethanol abuse in an outpatient program for alcoholics Biomed Soc Aspects Alcohol Alcohol 805 1988 357 360
123. F. Corrales, M. Pajares, M. Pliego, P. Ortiz, J. Moreno, and J. Puerta Effect of S adenosylmethionine treatment on methionine intolerance in alcoholic cirrhosis J Hepatol 13 Suppl. 2 1991 S111
124. A. Diaz Belmont, R. Dominguez Henkel, and F. Uribe Ancira Parenteral S-adenosylmethionine compared to placebos in the treatment of alcoholic liver diseases Ann Med Intern 13 1 1996 9 15
125. C. Loguercio, G. Nardi, F. Argenzio, C. Aurilio, E. Petrone, and A. Grella Effect of S-adenosyl-l-methionine administration on red blood cell cysteine and glutathione levels in alcoholic patients with and without liver disease Alcohol Alcohol (Oxford, Oxfordshire) 1994 597 604
126. E. Trespi, R. Vigoni, C. Matti, and C. Colla TUDCA, UDCA and ademethionine (Ade) in the treatment of alcohol-induced liver damage J Hepatol 26 Suppl. 1 1997 128